Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-04-09. The firm aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. The company operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. The company offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. The company is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Follow-Up Questions
Qui est le CEO de Abattis Bioceuticals Corp ?
Mr. Robert Abenante est le Chief Executive Officer de Abattis Bioceuticals Corp, il a rejoint l'entreprise depuis 2017.
Quelle est la performance du prix de l'action ATTBF ?
Le prix actuel de ATTBF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Abattis Bioceuticals Corp ?
Abattis Bioceuticals Corp appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quelle est la capitalisation boursière de Abattis Bioceuticals Corp ?
La capitalisation boursière actuelle de Abattis Bioceuticals Corp est de $477.79999999999995
